Venetoclax and hypomethylating agents yield high response rates and favourable transplant outcomes in patients with newly diagnosed acute myeloid leukaemia

British Journal of Haematology ◽

10.1111/bjh.17996 ◽

2021 ◽

Author(s):

Amandeep Salhotra ◽

Ni‐Chun Tsai ◽

Jianying Zhang ◽

Dat Ngo ◽

Ahmed Aribi ◽

...

Keyword(s):

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Response Rates ◽

High Response ◽

Hypomethylating Agents ◽

Newly Diagnosed ◽

Transplant Outcomes ◽

Acute Myeloid

Download Full-text

Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial

The Lancet Oncology ◽

10.1016/s1470-2045(15)00362-9 ◽

2015 ◽

Vol 16 (16) ◽

pp. 1691-1699 ◽

Cited By ~ 191

Author(s):

Christoph Röllig ◽

Hubert Serve ◽

Andreas Hüttmann ◽

Richard Noppeney ◽

Carsten Müller-Tidow ◽

...

Keyword(s):

Randomised Controlled Trial ◽

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Standard Therapy ◽

Controlled Trial ◽

Phase 2 ◽

Newly Diagnosed ◽

Multicentre Phase ◽

Randomised Controlled ◽

Acute Myeloid

Download Full-text

Venetoclax combinations induce high response rates in newly diagnosed Acute Myeloid Leukemia patients ineligible for intensive chemotherapy in routine practice

American Journal of Hematology ◽

10.1002/ajh.26190 ◽

2021 ◽

Author(s):

Arie Apel ◽

Yakir Moshe ◽

Yishai Ofran ◽

Alexander Gural ◽

Ofir Wolach ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Myeloid Leukemia ◽

Response Rates ◽

High Response ◽

Routine Practice ◽

Intensive Chemotherapy ◽

Newly Diagnosed ◽

Acute Myeloid

Download Full-text

PKP-005 Prognostic impact of novel gene polymorphisms in newly diagnosed acute myeloid leukaemia adults undergoing induction chemotherapy: Abstract PKP-005 Table 1

European Journal of Hospital Pharmacy ◽

10.1136/ejhpharm-2015-000639.321 ◽

2015 ◽

Vol 22 (Suppl 1) ◽

pp. A133.1-A133

Author(s):

J Megías Vericat ◽

P Montesinos ◽

M Herrero ◽

F Moscardó ◽

V Bosó ◽

...

Keyword(s):

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Induction Chemotherapy ◽

Gene Polymorphisms ◽

Prognostic Impact ◽

Newly Diagnosed ◽

Novel Gene ◽

Acute Myeloid

Download Full-text

Early recovery of the platelet count after decitabine-based induction chemotherapy is a prognostic marker of superior response in elderly patients with newly diagnosed acute myeloid leukaemia

BMC Cancer ◽

10.1186/s12885-018-5160-5 ◽

2018 ◽

Vol 18 (1) ◽

Cited By ~ 1

Author(s):

Jiayu Huang ◽

Huihui Zhao ◽

Ming Hong ◽

Han Zhu ◽

Yu Zhu ◽

...

Keyword(s):

Platelet Count ◽

Elderly Patients ◽

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Prognostic Marker ◽

Induction Chemotherapy ◽

Newly Diagnosed ◽

Early Recovery ◽

Acute Myeloid

Download Full-text

Idarubicin, cytarabine, and nivolumab in patients with newly diagnosed acute myeloid leukaemia or high-risk myelodysplastic syndrome: a single-arm, phase 2 study

The Lancet Haematology ◽

10.1016/s2352-3026(19)30114-0 ◽

2019 ◽

Vol 6 (9) ◽

pp. e480-e488 ◽

Cited By ~ 19

Author(s):

Farhad Ravandi ◽

Rita Assi ◽

Naval Daver ◽

Christopher B Benton ◽

Tapan Kadia ◽

...

Keyword(s):

High Risk ◽

Acute Myeloid Leukaemia ◽

Myelodysplastic Syndrome ◽

Myeloid Leukaemia ◽

Phase 2 ◽

Newly Diagnosed ◽

Phase 2 Study ◽

Acute Myeloid

Download Full-text

Real‐world data on treatment patterns and outcomes of hypomethylating therapy in patients with newly diagnosed acute myeloid leukaemia aged ≥ 60 years

British Journal of Haematology ◽

10.1111/bjh.16410 ◽

2020 ◽

Vol 189 (1) ◽

Cited By ~ 2

Author(s):

Albin Österroos ◽

Anna Eriksson ◽

Petar Antunovic ◽

Jörg Cammenga ◽

Stefan Deneberg ◽

...

Keyword(s):

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Real World ◽

Treatment Patterns ◽

Newly Diagnosed ◽

Real World Data ◽

World Data ◽

Acute Myeloid

Download Full-text

A model for prediction ofFLT3-ITD andNPM1(withoutFLT3-ITD) positivity in patients with newly diagnosed acute myeloid leukaemia

British Journal of Haematology ◽

10.1111/bjh.12450 ◽

2013 ◽

Vol 163 (1) ◽

pp. 130-132

Author(s):

Fabiana Ostronoff ◽

Megan Othus ◽

Hagop M. Kantarjian ◽

Soheil Meshinchi ◽

Farhad Ravandi ◽

...

Keyword(s):

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Newly Diagnosed ◽

Acute Myeloid

Download Full-text

Overexpression of TP53 is associated with poor survival, but not with reduced response to hypomethylating agents in older patients with acute myeloid leukaemia

British Journal of Haematology ◽

10.1111/bjh.14166 ◽

2016 ◽

Vol 178 (5) ◽

pp. 810-812 ◽

Cited By ~ 5

Author(s):

Lieke H. van der Helm ◽

Gerbrig Berger ◽

Arjan Diepstra ◽

Gerwin Huls ◽

Edo Vellenga

Keyword(s):

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Older Patients ◽

Hypomethylating Agents ◽

Poor Survival ◽

Acute Myeloid

Download Full-text

Information needs of adults patients with newly diagnosed acute myeloid leukaemia (AML)

Critical Reviews in Oncology/Hematology ◽

10.1016/s1040-8428(08)70119-7 ◽

2008 ◽

Vol 68 ◽

pp. S51

Author(s):

H.Z. Mohamedali ◽

H. Breunis ◽

M. Minden ◽

S.M.H. Alibhai

Keyword(s):

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Information Needs ◽

Newly Diagnosed ◽

Acute Myeloid

Download Full-text

Therapeutic effects of different regimens for induction therapy in elderly patients more than 50 years old with newly diagnosed acute myeloid leukaemia

Translational Cancer Research ◽

10.21037/tcr.2018.12.21 ◽

2018 ◽

Vol 7 (6) ◽

pp. 1675-1681

Author(s):

Junmei Liu ◽

Liang Zhong ◽

Juanjuan Yao ◽

Pengqiang Zhong ◽

Zhen Yuan ◽

...

Keyword(s):

Elderly Patients ◽

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Induction Therapy ◽

Therapeutic Effects ◽

Newly Diagnosed ◽

Acute Myeloid

Download Full-text